Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
20 Setembro 2023 - 9:30AM
Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering
drug-eluting biomatrix products, today announced that Dr. Randy
Mills, President and Chief Executive Officer, will participate on a
panel at the Cantor Global Healthcare Conference. The panel
discussion will take place in New York on Wednesday, September 27,
2023, at 8:00 am ET.
A live webcast of the panel can be accessed by
visiting the Company’s Events & Presentations webpage or by
clicking here. A replay will be available on the Company’s website
following the event.
Institutional investors interested in meeting
with management during the conference may reach out to their Cantor
Fitzgerald representative.
About Elutia
Elutia develops and commercializes biologic
products to improve compatibility between medical devices and the
patients who need them. With a growing population in need of
implantable technologies, Elutia’s mission is humanizing medicine
so patients can thrive without compromise. For more information,
visit www.Elutia.com.
Investors:Matt SteinbergFINN
Partnersmatt.steinberg@finnpartners.com
Elutia (NASDAQ:ELUT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Elutia (NASDAQ:ELUT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024